ID   UACC-2534
AC   CVCL_M452
SY   UACC 2534; UACC2534; University of Arizona Cell Culture-2534
DR   BTO; BTO:0005897
DR   Cosmic; 1211155
DR   Wikidata; Q54973822
RX   PubMed=10952317;
RX   PubMed=23039341;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=10952317; DOI=10.1038/35020115;
RA   Bittner M., Meltzer P.S., Chen Y.-D., Jiang Y., Seftor E.A.,
RA   Hendrix M.J.C., Radmacher M.D., Simon R.M., Yakhini Z., Ben-Dor A.,
RA   Sampas N., Dougherty E., Wang E., Marincola F.M., Gooden G.C., Lueders J.,
RA   Glatfelter A., Pollock P.M., Carpten J.D., Gillanders E.M., Leja D.,
RA   Dietrich K., Beaudry C., Berens M.E., Alberts D.S., Sondak V.K.,
RA   Hayward N.K., Trent J.M.;
RT   "Molecular classification of cutaneous malignant melanoma by gene
RT   expression profiling.";
RL   Nature 406:536-540(2000).
//
RX   PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420;
RA   Byron S.A., Loch D.C., Wellens C.L., Wortmann A., Wu J.-Y., Wang J.,
RA   Nomoto K., Pollock P.M.;
RT   "Sensitivity to the MEK inhibitor E6201 in melanoma cells is
RT   associated with mutant BRAF and wildtype PTEN status.";
RL   Mol. Cancer 11:75.1-75.15(2012).
//
RX   PubMed=24879157; DOI=10.4161/auto.28594; PMCID=PMC4091172;
RA   Goodall M.L., Wang T., Martin K.R., Kortus M.G., Kauffman A.L.,
RA   Trent J.M., Gately S., MacKeigan J.P.;
RT   "Development of potent autophagy inhibitors that sensitize oncogenic
RT   BRAF V600E mutant melanoma tumor cells to vemurafenib.";
RL   Autophagy 10:1120-1136(2014).
//